1416 Results

People

  1. Motzer
    Motzer
  2. Vickers
    Vickers
  3. Hudis
    Hudis
  4. Norton
    Norton
  5. Saltz
    Saltz
  6. O'Reilly
    O'Reilly
  7. Mao
    Mao
  8. Morris
    Morris
  9. Seidman
    Seidman
  10. Kris
    Kris

Groups

  1. Department of Medicine (753)
  2. Solid Tumor Oncology Division (541)
  3. Population Sciences Research Program (259)
  4. Survivorship Research (256)
  5. Surgery (244)
  6. Epidemiology and Biostatistics (187)
  7. Hematologic Malignancies, Division of (169)
  8. Genitourinary Oncology Service (160)
  9. Center for Hematologic Malignancies (142)
  10. Gastrointestinal Oncology Service (126)
  1. "randomized controlled trial"
Formats
  1. Journal Article (1353)
  2. Review (19)
  3. Conference Paper (17)
  4. Editorial (9)
  5. Correspondence (5)
  6. Research Letter (5)
  7. Meeting Abstract (4)
  8. Guidelines (3)
  9. Book Section (1)
Groups
  1. Department of Medicine (753)
  2. Solid Tumor Oncology Division (541)
  3. Population Sciences Research Program (259)
  4. Survivorship Research (256)
  5. Surgery (244)
  6. Epidemiology and Biostatistics (187)

More Groups

People
  1. Robert Motzer (83)
  2. Andrew Vickers (48)
  3. Larry Norton (34)
  4. Clifford Hudis (33)
  5. Leonard Saltz (32)
  6. Eileen O'Reilly (25)

More People

Years
  1. 2025 (63)
  2. 2024 (165)
  3. 2023 (110)
  4. 2022 (81)
  5. 2021 (39)
  6. 2020 (51)

More Years

Publications
  1. Journal of Clinical Oncology (164)
  2. New England Journal of Medicine (65)
  3. Lancet Oncology (46)
  4. Cancer (42)
  5. Clinical Cancer Research (42)
  6. European Urology (26)

More Publications

Publishers
  1. Elsevier Inc. (187)
  2. American Society of Clinical Oncology (170)
  3. Elsevier Science, Inc. (138)
  4. Springer (79)
  5. Lippincott Williams & Wilkins (72)
  6. Wiley Blackwell (71)

More Publishers

Results (1416)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Complementary low-level laser therapy for breast cancer-related lymphedema: A pilot, double-blind, randomized, placebo-controlled study
    Journal Article

    Kilmartin, L.; Denham, T.; Fu, M. R.; Yu, G.; Kuo, T. T.; Axelrod, D.; Guth, A. A.
    Lasers in Medical Science (2020)

    Fulltext@MSK | Save
  • Interobserver agreement of (18)F-fluorodeoxyglucose positron-emission tomography combined with low-dose computed tomography for occult cancer screening in patients with unprovoked venous thromboembolism
    Research Letter

    Robin, P.; Grewal, R. K.; Le Roux, P. Y.; Le Gal, G.; Salaun, P. Y.
    Thrombosis Research (2020)

    Fulltext@MSK | Save
  • Cancer-related communication during sessions of family therapy at the end of life
    Journal Article

    Zaider, T. I.; Kissane, D. W.; Schofield, E.; Li, Y.; Masterson, M.
    Psycho-Oncology (2020)

    Fulltext@MSK | Save
  • Transcriptomic signatures related to the obesity paradox in patients with clear cell renal cell carcinoma: A cohort study
    Journal Article

    Sanchez, A.; Furberg, H.; Kuo, F.; Vuong, L.; Ged, Y.; Patil, S.; Ostrovnaya, I.; Petruzella, S.; Reising, A.; Patel, P.; more...
    Lancet Oncology (2020)

    Fulltext@MSK | Save
  • Belantamab mafodotin for relapsed or refractory multiple myeloma (DREAMM-2): A two-arm, randomised, open-label, phase 2 study
    Journal Article

    Lonial, S.; Lee, H. C.; Badros, A.; Trudel, S.; Nooka, A. K.; Chari, A.; Abdallah, A. O.; Callander, N.; Lendvai, N.; Sborov, D.; more...
    Lancet Oncology (2020)

    Fulltext@MSK | Save
  • Efficacy and safety of trifluridine/tipiracil treatment in patients with metastatic gastric cancer who had undergone gastrectomy: Subgroup analyses of a randomized clinical trial
    Journal Article

    Ilson, D. H.; Tabernero, J.; Prokharau, A.; Arkenau, H. T.; Ghidini, M.; Fujitani, K.; Van Cutsem, E.; Thuss-Patience, P.; Beretta, G. D.; Mansoor, W.; more...
    JAMA Oncology (2020)

    Fulltext@MSK | Save
  • Pembrolizumab versus chemotherapy in recurrent, advanced urothelial cancer in Japanese patients: A subgroup analysis of the phase 3 KEYNOTE-045 trial
    Journal Article

    Nishiyama, H.; Yamamoto, Y.; Sassa, N.; Nishimura, K.; Fujimoto, K.; Fukasawa, S.; Yokoyama, M.; Enokida, H.; Takahashi, K.; Tanaka, Y.; more...
    International Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Polatuzumab vedotin in relapsed or refractory diffuse large B-cell lymphoma
    Journal Article

    Sehn, L. H.; Herrera, A. F.; Flowers, C. R.; Kamdar, M. K.; McMillan, A.; Hertzberg, M.; Assouline, S.; Kim, T. M.; Kim, W. S.; Ozcan, M.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • The Predictive Approaches to Treatment effect Heterogeneity (PATH) statement
    Journal Article

    Kent, D. M.; Paulus, J. K.; van Klaveren, D.; D'Agostino, R.; Goodman, S.; Hayward, R.; Ioannidis, J. P. A.; Patrick-Lake, B.; Morton, S.; Pencina, M.; more...
    Annals of Internal Medicine (2020)

    Fulltext@MSK | Save
  • Creating a synthetic clinical trial: Comparative effectiveness analyses using an electronic medical record
    Journal Article

    Zauderer, M. G.; Grigorenko, A.; May, P.; Kastango, N.; Wagner, I.; Caroline, A.; Kris, M. G.
    JCO Clinical Cancer Informatics (2019)

    Fulltext@MSK | Save